ACHP submitted a letter to Congress in response to draft legislation with feedback on how to best serve dually eligible populations.
ACHP is the only national payer group pushing for comprehensive drug pricing reform. Allowing Medicare to negotiate for lower prescription drug prices is an important step toward better health care for all.
ACHP looks forward to continuing to work with policymakers to foster innovation and competition that puts consumers first.
By offering lower costs, more benefits and better outcomes, Medicare Advantage is increasingly becoming the Choice of America’s Seniors.
ACHP is disappointed by policies included in CMS’ final RADV rule and calls on the agency to reopen the rule for comment.